Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
7.59
-0.85 (-10.07%)
At close: Oct 2, 2026, 4:00 PM EDT
7.65
+0.06 (0.79%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.04 billion as of October 2, 2026. Its market cap has decreased by -5.17% in one year.
Market Cap
1.04B
Enterprise Value
604.77M
1-Year Change
-5.17%
Ranking
Category
Stock Price
$7.59
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.04B, an increase of 501.44%. That is a compound annual growth rate of 25.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.04B | -26.30% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.28B |
| MannKind | 1.27B |
| Replimune Group | 1.27B |
| Damora Therapeutics | 1.25B |
| Avalyn Pharma | 1.22B |
| First Tracks Biotherapeutics | 1.21B |
| Bicara Therapeutics | 1.20B |
| LB Pharmaceuticals | 1.20B |